| Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Q Yang, TE Graham, N Mody, F Preitner, OD Peroni, JM Zabolotny, ... Nature 436 (7049), 356-362, 2005 | 3014 | 2005 |
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ... Nature genetics 42 (2), 105-116, 2010 | 2611 | 2010 |
| Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC … J Spranger, A Kroke, M Mohlig, K Hoffmann, MM Bergmann, M Ristow, ... Diabetes 52 (3), 812-817, 2003 | 2166 | 2003 |
| Adiponectin and protection against type 2 diabetes mellitus J Spranger, A Kroke, M Möhlig, MM Bergmann, M Ristow, H Boeing, ... The Lancet 361 (9353), 226-228, 2003 | 1575 | 2003 |
| An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes MB Schulze, K Hoffmann, H Boeing, J Linseisen, S Rohrmann, M Mohlig, ... Diabetes care 30 (3), 510-515, 2007 | 567 | 2007 |
| Cereal fiber improves whole-body insulin sensitivity in overweight and obese women MO Weickert, M Möhlig, C Schöfl, AM Arafat, B Otto, H Viehoff, ... Diabetes care 29 (4), 775-780, 2006 | 451 | 2006 |
| Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I … M Bidlingmaier, N Friedrich, RT Emeny, J Spranger, OD Wolthers, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), 1712-1721, 2014 | 410 | 2014 |
| Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity AS Dimas, V Lagou, A Barker, JW Knowles, R Mägi, MF Hivert, A Benazzo, ... Diabetes 63 (6), 2158-2171, 2014 | 401 | 2014 |
| Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease J Spranger, M Osterhoff, M Reimann, M Mohlig, M Ristow, MK Francis, ... Diabetes 50 (12), 2641-2645, 2001 | 377 | 2001 |
| Changes of adiponectin oligomer composition by moderate weight reduction T Bobbert, H Rochlitz, U Wegewitz, S Akpulat, K Mai, MO Weickert, ... Diabetes 54 (9), 2712-2719, 2005 | 373 | 2005 |
| MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency K Clément, H Biebermann, IS Farooqi, L Van der Ploeg, B Wolters, ... Nature medicine 24 (5), 551-555, 2018 | 317 | 2018 |
| A high normal TSH is associated with the metabolic syndrome S Ruhla, MO Weickert, AM Arafat, M Osterhoff, F Isken, J Spranger, ... Clinical endocrinology 72 (5), 696-701, 2010 | 315 | 2010 |
| The polycystic ovary syndrome per se is not associated with increased chronic inflammation M Möhlig, J Spranger, M Osterhoff, M Ristow, AF Pfeiffer, T Schill, ... European Journal of Endocrinology 150 (4), 525-532, 2004 | 274 | 2004 |
| A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity C Kedor, H Freitag, L Meyer-Arndt, K Wittke, LG Hanitsch, T Zoller, ... Nature communications 13 (1), 5104, 2022 | 273 | 2022 |
| Impact of cereal fibre on glucose-regulating factors MO Weickert, M Mohlig, C Koebnick, JJ Holst, P Namsolleck, M Ristow, ... Diabetologia 48, 2343-2353, 2005 | 266 | 2005 |
| Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans M Möhlig, J Spranger, B Otto, M Ristow, M Tschöp, AFH Pfeiffer Journal of Endocrinological Investigation 25, RC36-RC38, 2002 | 266 | 2002 |
| Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells J Spranger, S Verma, I Göhring, T Bobbert, J Seifert, AL Sindler, ... Diabetes 55 (1), 141-147, 2006 | 264 | 2006 |
| A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam Study cohort C Heidemann, K Hoffmann, J Spranger, K Klipstein-Grobusch, M Möhlig, ... Diabetologia 48, 1126-1134, 2005 | 263 | 2005 |
| Fibroblast growth factor 21 mediates specific glucagon actions KM Habegger, K Stemmer, C Cheng, TD Müller, KM Heppner, N Ottaway, ... Diabetes 62 (5), 1453-1463, 2013 | 260 | 2013 |
| Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women HP Kopp, K Krzyzanowska, M Möhlig, J Spranger, AFH Pfeiffer, ... International Journal of Obesity 29 (7), 766-771, 2005 | 251 | 2005 |
